Comparison between liposomal formulations of amphotericin B

Medical Mycology
J P Adler-MoorePeter G Pappas

Abstract

Given the clinical success of commercial amphotericin B lipid products, investigators have begun making generic formulations of liposomal amphotericin B. Generic medicines are an attractive approach to help decrease the cost and accessibility to healthcare, provided that appropriate studies are performed to ensure bioequivalence with the parent product. This is of particular concern for liposomal drugs such as amphotericin B where liposomes are used as a carrier system to reduce the toxicity of the active agent. A favorable therapeutic profile for this form of the drug has to include the proper chemical composition along with strictly controlled manufacturing processes. Studies have shown that a comparison of liposomal amphotericin B products with different or the same chemical compositions, using different methods of production, will vary in size, and have significantly dissimilar in vitro and in vivo toxicities along with reduced efficacy. These results underscore the importance of establishing appropriate bioequivalence testing for liposome products to ensure uniformity of their therapeutic index.

References

May 1, 1991·Antimicrobial Agents and Chemotherapy·E WilsonD P Speert
Aug 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E AnaissieG P Bodey
Oct 1, 1993·Antimicrobial Agents and Chemotherapy·Y TokudaH Yamaguchi
Sep 24, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·P V BodheN A Kshirsagar
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardUNKNOWN L Amph/ABLC Collaborative Study Group
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·S Sundar
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Gilbert Deray
Jul 18, 2002·Annals of Internal Medicine·Philip C JohnsonUNKNOWN U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jan 31, 2003·The Journal of Antimicrobial Chemotherapy·J García-De-LomasC Gimeno
Jan 24, 2004·The Journal of Antimicrobial Chemotherapy·Rogelio López-VélezUNKNOWN Spanish HIV-Leishmania Study Group
Jan 19, 2006·Clinical Microbiology Reviews·Simon L CroftAlan H Fairlamb
May 19, 2006·International Journal of Antimicrobial Agents·Michael Kleinberg
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelyUNKNOWN AmBiLoad Trial Study Group
May 8, 2007·Lancet·Ernst-Rüdiger KuseUNKNOWN Micafungin Invasive Candidiasis Working Group
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Joseph WheatUNKNOWN Infectious Diseases Society of America
Oct 31, 2007·Antimicrobial Agents and Chemotherapy·Jon A OlsonRichard T Proffitt
Feb 12, 2010·The New England Journal of Medicine·Shyam SundarHenry W Murray
Dec 2, 2011·Indian Journal of Pharmaceutical Sciences·M P JadhavNilima A Kshirsagar
Jun 14, 2012·PloS One·Jorge AlvarUNKNOWN WHO Leishmaniasis Control Team
Oct 2, 2012·Frontiers in Microbiology·Ana C Mesa-ArangoOscar Zaragoza
Nov 22, 2012·Expert Opinion on Emerging Drugs·Manica BalasegaramFrançois Chappuis
Feb 13, 2013·Clinical Drug Investigation·João F Lacerda, Carlos Meneses Oliveira
Aug 13, 2013·Expert Opinion on Drug Safety·Angela S LooThomas J Walsh
Nov 23, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre TattevinRémy Gauzit
Aug 12, 2014·The Lancet Global Health·Thomas P C Dorlo, Manica Balasegaram
Dec 17, 2014·The American Journal of Tropical Medicine and Hygiene·Shyam SundarJaya Chakravarty

❮ Previous
Next ❯

Citations

Apr 15, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Roberta Della PepaUNKNOWN SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia)
Jan 24, 2017·Expert Review of Anti-infective Therapy·Sarah LofgrenDavid R Boulware
Aug 18, 2017·The Journal of Pharmacy and Pharmacology·Fernanda S ToninFernando Fernandez-Llimos
Dec 22, 2017·Antimicrobial Agents and Chemotherapy·Gert-Jan WijnantSimon L Croft
Jan 8, 2020·Pharmaceutics·Célia Faustino, Lídia Pinheiro
Mar 1, 2019·Clinical Microbiology Reviews·Renáta TóthAttila Gácser
May 16, 2018·Antimicrobial Agents and Chemotherapy·Alicia López-SánchezSusana Torrado
Aug 23, 2019·Expert Opinion on Drug Delivery·Juliane S LanzaFrédéric Frézard
Aug 18, 2017·Journal of Veterinary Pharmacology and Therapeutics·B Bingöl, T Bakirel
Feb 2, 2021·Infectious Diseases and Therapy·Francelise B CavassinFlávio Queiroz-Telles
Apr 9, 2021·Progress in Lipid Research·Alexsandra Conceição ApolinárioLuciana Biagini Lopes
Jul 31, 2021·Expert Review of Anti-infective Therapy·Daniel Echeverria-EsnalSantiago Grau
Jan 3, 2018·Journal of Medicinal Chemistry·Na LiuChunquan Sheng
May 23, 2018·Molecular Pharmaceutics·Melanie A Hutnick, Jonathan K Pokorski
Nov 25, 2021·Expert Opinion on Drug Discovery·Bilal Zulfiqar, Vicky M Avery

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
J Tollemar, O Ringdén
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
A S O'Marcaigh, D L Betcher
European Journal of Cancer & Clinical Oncology
T F Patterson, V T Andriole
Methods in Enzymology
Agatha W K NgG Lopez-Berestein
© 2022 Meta ULC. All rights reserved